Čájehuvvojit 1 - 12 oktiibuot 12 bohtosis ohcui ', ohcanáigi: 0,02s Aiddostahte ozu
  1. 1

    Adaptive clinical trials conclusion and future directions /

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  2. 2

    Adaptive clinical trials overview, part 2 of 2 /

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  3. 3

    Case studies of adaptive early phase trials

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  4. 4

    Biomarkers and surrogate endpoints in randomized clinical trials

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  5. 5

    Adaptive clinical trials conclusion and future directions /

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  6. 6

    Adaptive clinical trials overview, part 2 of 2 /

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  7. 7

    Case studies of adaptive early phase trials

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  8. 8

    Biomarkers and surrogate endpoints in randomized clinical trials

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  9. 9

    Biomarkers and surrogate endpoints in randomized clinical trials

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  10. 10

    Case studies of adaptive early phase trials

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  11. 11

    Adaptive clinical trials conclusion and future directions /

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video
  12. 12

    Adaptive clinical trials overview, part 2 of 2 /

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Video